We developed a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot to detect CMV-specific IgM in human sera. The new test contains four viral proteins (vp150, vp82, vp65, and vp28) purified from viral particles and four recombinant proteins (rp150, rp130, rp52, and rp38) purified from Escherichia coli. These antigens were individually loaded onto nitrocellulose strips, and the strips were then used to detect CMV-specific IgM by using a mu-specific conjugate. The new assay was evaluated in parallel with one or two IgM enzyme-linked immunosorbent assays (ELISAs) to test 592 serum samples from different groups of latently or acutely infected individuals. The sensitivity of the new assay with respect to the consensus of two ELISAs was 100%, the specificity was 98.6%, the positive predictive value was 96.9%, and the negative predictive value was 100%. We also evaluated the new test by testing sera from pregnant women and transplant recipients with a known clinical history. Our results suggest that the new test combines high sensitivity with high specificity, characteristics that are mutually exclusive with the other commercially available tests. Furthermore, a statistically significant correlation was observed between the number of IgM-reactive bands and the elevated risk of transmission from CMV-infected pregnant women to their offspring.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC105325 | PMC |
| http://dx.doi.org/10.1128/JCM.36.11.3337-3341.1998 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of the impact of cytomegalovirus seropositivity on blood parameters in renal hemodialysis patients.
Egypt J Immunol
July 2024
Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Article Synopsis
- * A study involving 45 ESRD patients found a higher prevalence of CMV-IgG (42.2%) compared to a control group (22.2%), but similar levels of CMV-IgM between the two groups.
- * CMV seropositivity is linked to a higher rate of anemia in ESRD patients (77.3% in seropositive vs 47.8% in seronegative), highlighting the importance of early detection and monitoring of CMV to improve patient outcomes
Performance of eight commercial immunoassays for the detection of cytomegalovirus-specific IgM antibodies in pregnancy - no test fits all needs.
J Clin Microbiol
April 2024
Laboratory Prof. Gisela Enders and Colleagues, MVZ, Stuttgart, Germany.
Detection of cytomegalovirus (CMV)-specific immunoglobulin M (IgM) antibodies as first-line serologic diagnosis plays an important role in identifying CMV primary infection during pregnancy. The performance characteristics of eight commercially available CMV IgM assays were compared. Sensitivity and IgM antibody kinetics were assessed using 100 acute phase and follow-up sera from 39 pregnant women with a well-defined onset of CMV primary infection.
View Article and Find Full Text PDFA high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production.
Med Microbiol Immunol
February 2023
Basic Health Sciences Department, Federal University of Health Sciences of Porto Alegre (UFCSPA), Immunotherapy Laboratory-UFCSPA, R. Sarmento Leite, 245-Centro Histórico, Porto Alegre, 90050-170, Brazil.
Human cytomegalovirus (CMV) is a widespread persistent herpes virus requiring lifelong immune surveillance to maintain latency. Such long-term interactions with the immune system may be associated with deleterious effects including immune exhaustion and senescence. Regarding the COVID-19 pandemic, we asked whether CMV-specific cellular and humoral activity could influence immune responses toward SARS-CoV-2 and/or disease severity.
View Article and Find Full Text PDFPitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review.
J Clin Med
August 2022
Department of Regional Neonatal-Perinatal Medicine, Hamamatsu University School of Medicine, Hamamatsu 4313192, Japan.
Cytomegalovirus (CMV) is the most common cause of intrauterine infection and serological assays are the primary tools for assessing CMV infections during pregnancy. CMV-specific immunoglobulin M (IgM) antibodies have been used as a diagnostic marker for primary CMV infection in pregnant women, although CMV-IgM has been detected in non-primary CMV infections. IgG avidity testing may aid the distinguishing of primary from non-primary CMV infection; however, there is no standardized assay for detecting this difference.
View Article and Find Full Text PDFAssociation Between First-Trimester Maternal Cytomegalovirus Infection and Stillbirth: A Prospective Cohort Study.
Front Pediatr
March 2022
Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
Background: Given that the time lag between cytomegalovirus (CMV) screening and diagnosed testing, a better knowledge of the association between pregnant women with CMV screening test positive and stillbirth in an epidemiological perspective was required to assist people being counseled reframe their pregnancy and birth plans based on the magnitude of the risk.
Methods: This study recruited 44048 eligible pregnant women from March 13, 2013 to December 31, 2019. Serological tests including CMV-specific IgM and IgG, and IgG avidity index were used to screen for maternal CMV infection and were measured by automated chemiluminescence immunoassay.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!